Search Results - Tesmoingt, C.

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors

    Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors by Abbar, B., De Castelbajac, V., Gougis, P., Assoun, S., Pluvy, J., Tesmoingt, C., Théou-Anton, N., Cazes, A., Namour, C., Khalil, A., Gounant, V., Besse, B., Zalcman, G., Brosseau, S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    5PSQ-031 Pneumocystis carinii pneumonia prevention in lung transplantation: is atovaquone effective?

    5PSQ-031 Pneumocystis carinii pneumonia prevention in lung transplantation: is atovaquone effective? by Bonnet, M, Guenée, C, Dauriat, G, Tesmoingt, C

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    4CPS-256 Discharge medication reconciliation: evaluation of a 7-months activity

    4CPS-256 Discharge medication reconciliation: evaluation of a 7-months activity by Bottois, C, Giraud, J, Alexandra, JF, Guenée, C, Arnaud, P, Tesmoingt, C

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    DI-069 Cutaneous tolerance to long term anakinra therapy: report of a 9 year experience and review of french pharmacovigilance

    DI-069 Cutaneous tolerance to long term anakinra therapy: report of a 9 year experience and review of french pharmacovigilance by Bonsergent, M, Giraud, J, Asgari, R, Deschamps, L, Ottaviani, S, Bejar, C, Papo, T, Alexandra, JF, Tesmoingt, C

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: